SOURCE: Xtalks

Xtalks Webinars

October 13, 2015 07:00 ET

Top News Stories You Might have Missed From Xtalks

Xtalks Provides Current Articles Daily in the Life Science Industry

TORONTO, ON--(Marketwired - October 13, 2015) - Check out all news stories here: Subscribe to our weekly newsletter:

Shares in DBV Up Following Release of Phase IIb Trial Data for Peanut Allergy Drug -
(Oct 9) DBV Technologies stocks rose by as much as 13 percent after the company released promising Phase IIb clinical trial data, for its peanut allergy therapy.

Hands-Free Smartphone Device Could Improve Vein Location for Injection Administration -
(Oct 9) A 3-D printed smartphone device fitted with an infrared-filtered lens, has been developed by researchers at Nottingham Trent University in the UK.

Study Finds Flaw in GC-MS Analysis of Small Molecules -
(Oct 8) Research conducted at The Scripps Research Institute (TSRI), has identified a fundamental flaw in a common laboratory technique: gas chromatography mass spectrometry (GC-MS) changes the small molecule samples, as it performs its analysis.

Relationship Between Big Data and Big Pharma Mutually Beneficial, Says Roche CEO -
(Oct 8) According to Roche's CEO, Severin Schwan, Big Pharma should strive to form digital partnerships in order to harness the potential of Big Data.

Trans-Pacific Partnership and Drug Patent Exclusivity -
(Oct 7) Though the US representatives argued in favour of a 12-year patent protection policy -- the current term of a drug patent in the country -- they faced opposition from the other nations involved in the talks.

Role of Sugars in Antibody Function -
(Oct 7) Research conducted at the University of Zurich has now identified that a specific sugar -- sialic acid -- is key to protecting host cells from attack by antibodies.

Exposure to Beneficial Bacteria May Prevent Asthma in Children -
(Oct 6) Three month old children who are missing four beneficial strains of bacteria appear to face a heightened chance of developing asthma at age three.

Drugs That Give Same Health Benefits as Exercise Could Be in the Pipeline -
(Oct 5) Exercise isn't always a viable treatment option, so developing drugs that mimic the effects may be a new way forward.


Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Contact Information